Iran Launches WhartoCell, Umbilical Cord Cell Therapy for Osteoarthritis

Tasnim News Agency · June 28, 2026 General

TEHRAN (Tasnim) – An Iranian knowledge-based cell therapy product made from umbilical cord-derived stem cells has entered clinical use after Iran's Food and Drug Administration authorized it for treating osteoarthritis.

← Back to Feed